PopulationsHumansPreprint

GLP-1 Receptor Agonist Exposure and Diabetic Retinopathy Progression: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Analysis

Research Square

The paper

Ross C, Parmar UPS, Gong D et al.

Research Square · 21 Sep 2026 · Preprint, not peer-reviewed

doi.org/10.21203/rs.3.rs-11063573/v1

GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026